The global leukemia therapeutics market size was estimated at USD 18.9 billion in 2024 and is projected to reach USD 36.0 billion by 2033, growing at a CAGR of 7.4% from 2025 to 2033. The market is expanding due to a rising global prevalence of acute and chronic leukemia across all age g... Read More »
November 2025The global bone density supplements market size was valued at USD 2.8 billion in 2024 and is projected to grow from USD 3.3 billion in 2026 to USD 6.2 billion by 2033, at a CAGR of 9.1% from 2025 to 2033. North America dominated the market, accounting for a revenue share of 34.2% in 2024. The growing incidence of os... Read More »
November 2025The global Antibody drug conjugate market size was valued at USD 14.5 billion in 2025 and is projected to grow from USD 16.7 billion in 2026 to USD 32.1 billion by 2033, at a CAGR of 11.5% from 2026 to 2033. North America dominated the antibody drug conjugate market with the largest revenue share of 39.80% in 2025.&... Read More »
November 2025The global benzodiazepine drugs market size was estimated at USD 2.83 billion in 2024 and is projected to reach USD 3.85 billion by 2033, growing at a CAGR of 3.48% from 2025 to 2033. The industry is driven by the increasing prevalence of anxiety disorders, insomnia, and seizure-related ... Read More »
November 2025The global preclinical bioanalytical testing services market size was valued at USD 1.2 billion in 2024 and is projected to grow from USD 1.3 billion in 2026 to USD 2.6 billion by 2033, at a CAGR of 9.8% from 2025 to 2033. North America dominated the market, accounting for a revenue shar... Read More »
November 2025The global testicular cancer drugs market size was estimated at USD 1.08 billion in 2024 and is projected to reach USD 1.97 billion by 2033, growing at a CAGR of 6.9% from 2025 to 2033. The market is primarily driven by improved healthcare infrastructure and access, especially in emergin... Read More »
November 2025The global anemia supplements market size was estimated at USD 1.85 billion in 2024 and is projected to reach USD 3.71 billion by 2033, growing at a CAGR of 8.44% from 2025 to 2033. Market expansion is driven by the rising global prevalence of iron deficiency anemia, the increasing adopt... Read More »
November 2025The global thrombosis drugs market size was estimated at USD 26.11 billion in 2024 and is projected to reach USD 52.30 billion by 2033, growing at a CAGR of 8.03% from 2025 to 2033. The growth of this market is primarily driven by the high prevalence of cardiovascular diseases (CVDs... Read More »
November 2025The global benign positional vertigo market size was estimated at USD 1.84 billion in 2024 and is projected to reach USD 2.73 billion by 2033, growing at a CAGR of 4.5% from 2025 to 2033. The benign positional vertigo industry is driven by the growing prevalence of vestibular disorders, ... Read More »
November 2025The global cancer cachexia market size was estimated at USD 2.54 billion in 2024 and is projected to reach USD 3.90 billion by 2033, growing at a CAGR of 4.86% from 2025 to 2033. The rising cancer incidence and more patients with cachexia, and growing recognition of cachexia’s clin... Read More »
November 2025The global pulmonary arterial hypertension market size was estimated at USD 8.02 billion in 2024 and is projected to reach USD 13.34 billion by 2033, growing at a CAGR of 5.9% from 2025 to 2033. The market growth is majorly attributed to increasing support from government & healthcar... Read More »
November 2025The global pericardium diseases market size was estimated at USD 2.96 billion in 2024 and is projected to reach USD 5.06 billion by 2033, growing at a CAGR of 6.14% from 2025 to 2033. The growth is driven by the prevalence of cardiovascular conditions, aging populations, and improved dia... Read More »
November 2025The global hemorrhoids treatment market size was estimated at USD 762.99 million in 2024 and is projected to reach USD 1,465.28 million by 2033, growing at a CAGR of 7.5% from 2025 to 2033. The increasing prevalence of hemorrhoidal disorders is driving market growth, influenced by sedentary lifestyles, poor diets, r... Read More »
October 2025The global acute pancreatitis market size was estimated at USD 3.37 billion in 2024 and is projected to reach USD 5.60 billion by 2033, growing at a CAGR of 5.8% from 2025 to 2033. The market is largely driven by rising awareness of pancreatic health, an increasing prevalence of lifestyl... Read More »
October 2025The global thyroid support supplements market size was estimated at USD 1.87 billion in 2024 and is projected to reach USD 4.08 billion by 2033, growing at a CAGR of 9.29% from 2025 to 2033. Increasingly, consumers are looking for natural and herbal supplements with ingredients such as i... Read More »
October 2025The global antithrombin market size was estimated at USD 658.4 million in 2024 and is projected to reach USD 997.2 million by 2033, growing at a CAGR of 4.7% from 2025 to 2033. The rising prevalence of coagulation disorders such as deep vein thrombosis, pulmonary embolism, and hereditary... Read More »
October 2025The global hyperkalemia drugs market size was valued at USD 1.2 billion in 2024 and is projected to grow from USD 1.6 billion in 2026 to USD 3.9 billion by 2033, at a CAGR of 13.8% from 2025 to 2033. The market growth is primarily driven by an aging population, increasing prevalence of c... Read More »
October 2025The global sinusitis drugs market size was estimated at USD 2.91 billion in 2024 and is projected to reach USD 4.49 billion by 2033, growing at a CAGR of 4.9% from 2025 to 2033. The industry is driven by the high prevalence of sinus-related conditions worldwide. Sinusitis, including acut... Read More »
October 2025The Canada endometriosis treatment market size was estimated at USD 53.58 million in 2024 and is projected to reach USD 156.71 million by 2033, growing at a CAGR of 13.26% from 2025 to 2033. The growth is driven by increasing awareness, advancements in treatment options, improved healthc... Read More »
October 2025The global hematuria treatment market size was estimated at USD 1,087.3 million in 2024 and is projected to reach USD 1,426.9 million by 2033, growing at a CAGR of 3.1% from 2025 to 2033. The market is driven by urological care and sustained by the growing prevalence of recurrent urinary... Read More »
October 2025